Enzymatic Biosensors are innovative analytical devices designed to detect and quantify specific substances by leveraging the catalytic activity of enzymes. These biosensors typically consist of a biorecognition element (enzyme), a transducer, and a signal-processing system. Enzymes act as molecular catalysts, facilitating biochemical reactions with high specificity and sensitivity. The transducer converts the enzymatic reaction into a measurable signal, such as an electrical, optical, or electrochemical output. Enzymatic biosensors find widespread application in various fields, including medical diagnostics, environmental monitoring, and food safety. Their specificity allows for the precise detection of target analytes, ranging from glucose and cholesterol in clinical settings to pollutants in environmental samples. The integration of nanotechnology and microfabrication techniques has enhanced the performance and miniaturization of enzymatic biosensors. These devices offer rapid and real-time detection capabilities, making them invaluable for point-of-care diagnostics and continuous monitoring. Challenges in enzymatic biosensor development include stability and immobilization of enzymes, but ongoing research aims to address these issues. The versatility and accuracy of enzymatic biosensors contribute to their increasing importance in advancing diagnostics and monitoring applications across diverse domains.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation